Company intelligence / Profile preview
Nestlé Health Science
- Ownership
- Private
- Employees
- ~12000
- Development stage
- Commercial
Overview
Nestlé Health Science offers a broad commercial portfolio of science-based consumer health products, medical nutrition solutions for specific patient populations across all ages and stages of life, and select pharmaceutical therapies. Its pipeline includes both marketed products and late-stage clinical programs through its subsidiaries/investments such as Aimmune Therapeutics’ approved peanut allergy treatment and Seres’ Phase III microbiome therapeutic.
- Therapeutic areas
- GastroenterologyOncologyImmunologyMetabolic Disorders
- Modalities
- Medical food/nutrition therapy productsSmall moleculeLive biotherapeutic product therapyProteinDevice
- Industry
- Pharma
Drug pipeline
12 assets11 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Nestlé Health Science.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nestlé Health Science.